271 related articles for article (PubMed ID: 12789264)
1. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
Stoecklin G; Gross B; Ming XF; Moroni C
Oncogene; 2003 Jun; 22(23):3554-61. PubMed ID: 12789264
[TBL] [Abstract][Full Text] [Related]
2. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements.
Stoecklin G; Stoeckle P; Lu M; Muehlemann O; Moroni C
RNA; 2001 Nov; 7(11):1578-88. PubMed ID: 11720287
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
4. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b.
Ciais D; Cherradi N; Bailly S; Grenier E; Berra E; Pouyssegur J; Lamarre J; Feige JJ
Oncogene; 2004 Nov; 23(53):8673-80. PubMed ID: 15467755
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA.
Nair AP; Hahn S; Banholzer R; Hirsch HH; Moroni C
Nature; 1994 May; 369(6477):239-42. PubMed ID: 8183344
[TBL] [Abstract][Full Text] [Related]
6. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
[TBL] [Abstract][Full Text] [Related]
7. Gene transduction of tristetraprolin or its active domain reduces TNF-alpha production by Jurkat T cells.
Suzuki E; Tsutsumi A; Goto D; Matsumoto I; Ito S; Otsu M; Onodera M; Takahashi S; Sato Y; Sumida T
Int J Mol Med; 2006 May; 17(5):801-9. PubMed ID: 16596264
[TBL] [Abstract][Full Text] [Related]
8. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity.
Nair AP; Hirsch HH; Moroni C
Oncogene; 1992 Oct; 7(10):1963-72. PubMed ID: 1408138
[TBL] [Abstract][Full Text] [Related]
9. Involvement of microRNA in AU-rich element-mediated mRNA instability.
Jing Q; Huang S; Guth S; Zarubin T; Motoyama A; Chen J; Di Padova F; Lin SC; Gram H; Han J
Cell; 2005 Mar; 120(5):623-34. PubMed ID: 15766526
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the function, expression, and subcellular distribution of human tristetraprolin.
Brooks SA; Connolly JE; Diegel RJ; Fava RA; Rigby WF
Arthritis Rheum; 2002 May; 46(5):1362-70. PubMed ID: 12115244
[TBL] [Abstract][Full Text] [Related]
11. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells.
Lin NY; Lin CT; Chang CJ
Biochem Biophys Res Commun; 2008 Jan; 365(1):69-74. PubMed ID: 17971298
[TBL] [Abstract][Full Text] [Related]
12. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins.
Blackshear PJ; Phillips RS; Ghosh S; Ramos SB; Richfield EK; Lai WS
Biol Reprod; 2005 Aug; 73(2):297-307. PubMed ID: 15814898
[TBL] [Abstract][Full Text] [Related]
13. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival.
Johnson BA; Geha M; Blackwell TK
Oncogene; 2000 Mar; 19(13):1657-64. PubMed ID: 10763822
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytes.
Lin NY; Lin CT; Chen YL; Chang CJ
FEBS J; 2007 Feb; 274(3):867-78. PubMed ID: 17288565
[TBL] [Abstract][Full Text] [Related]
15. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis.
Carrick DM; Lai WS; Blackshear PJ
Arthritis Res Ther; 2004; 6(6):248-64. PubMed ID: 15535838
[TBL] [Abstract][Full Text] [Related]
16. Interactions of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs.
Lai WS; Kennington EA; Blackshear PJ
J Biol Chem; 2002 Mar; 277(11):9606-13. PubMed ID: 11782475
[TBL] [Abstract][Full Text] [Related]
17. Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element.
Fukae J; Amasaki Y; Yamashita Y; Bohgaki T; Yasuda S; Jodo S; Atsumi T; Koike T
Arthritis Rheum; 2005 Sep; 52(9):2697-707. PubMed ID: 16142751
[TBL] [Abstract][Full Text] [Related]
18. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
Suswam E; Li Y; Zhang X; Gillespie GY; Li X; Shacka JJ; Lu L; Zheng L; King PH
Cancer Res; 2008 Feb; 68(3):674-82. PubMed ID: 18245466
[TBL] [Abstract][Full Text] [Related]
19. Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail.
Lai WS; Blackshear PJ
J Biol Chem; 2001 Jun; 276(25):23144-54. PubMed ID: 11279239
[TBL] [Abstract][Full Text] [Related]
20. Zinc inhibits turnover of labile mRNAs in intact cells.
Taylor GA; Blackshear PJ
J Cell Physiol; 1995 Mar; 162(3):378-87. PubMed ID: 7860645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
